Neutralizing Monoclonal Antibodies Block Human Immunodeficiency Virus Type 1 Infection of Dendritic Cells and Transmission to T Cells

Prevention of the initial infection of mucosal dendritic cells (DC) and interruption of the subsequent transmission of HIV-1 from DC to T cells are likely to be important attributes of an effective human immunodeficiency virus type 1 (HIV-1) vaccine. While anti-HIV-1 neutralizing antibodies have bee...

Полное описание

Библиографические подробности

Опубликовано в::	J Virol
Главные авторы:	Frankel, Sarah S., Steinman, Ralph M., Michael, Nelson L., Kim, Silvia Ratto, Bhardwaj, Nina, Pope, Melissa, Louder, Mark K., Ehrenberg, Philip K., Parren, Paul W. H. I., Burton, Dennis R., Katinger, Hermann, VanCott, Thomas C., Robb, Merlin L., Birx, Deborah L., Mascola, John R.
Формат:	Artigo
Язык:	Inglês
Опубликовано:	American Society for Microbiology (ASM) 1998
Предметы:	Viral Pathogenesis and Immunity
Online-ссылка:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC110490/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/9811714/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/jvi.72.12.9788-9794.1998
Метки:	Добавить метку Нет меток, Требуется 1-ая метка записи!